Found: 13
Select item for more details and to access through your institution.
Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. E111, doi. 10.1002/ajh.23996
- By:
- Publication type:
- Article
A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 1, p. 111, doi. 10.1002/ajh.22232
- By:
- Publication type:
- Article
Utility of positron emission tomography scans in mantle cell lymphoma.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 10, p. 841, doi. 10.1002/ajh.22126
- By:
- Publication type:
- Article
The Evolving Role of <sup>18</sup>F-FDG PET Scans in Patients with Aggressive non-Hodgkin's Lymphoma.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
Texture Analysis Identifies Distinct Radiomic Signals Associated with Survival in Hispanic Patients with Pancreatic Cancer.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis.
- Published in:
- Journal of Surgical Oncology, 2016, v. 114, n. 4, p. 451, doi. 10.1002/jso.24314
- By:
- Publication type:
- Article
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: overview of study protocols.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 640, doi. 10.1111/bjh.12801
- By:
- Publication type:
- Article
A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 3, p. 358, doi. 10.1111/bjh.12753
- By:
- Publication type:
- Article
Phase II clinical trial of nab‐paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cam4.7412
- By:
- Publication type:
- Article
Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article